Moligo Technologies Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
Moligo Technologies General Information
Description
Developer of deoxyribonucleic acid (DNA) strands technology designed to serve large experiments and clinical trials for enzymatic production. The company's proprietary enzyme-based technology produces deoxyribonucleic acid (DNA) strands with unprecedented purity, length, and scale, enabling researchers to bring gene editing, deoxyribonucleic acid (DNA) therapeutics, and diagnostics to a clinical and industrial level.
Contact Information
Website
www.moligotechnologies.comCorporate Office
- Anderstorpsvägen 16
- 171 51 Solna
- Sweden
Corporate Office
- Anderstorpsvägen 16
- 171 51 Solna
- Sweden
Moligo Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Early Stage VC | 01-Jan-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 23-Sep-2020 | $54.6K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 02-Jun-2020 | $54.6K | $54.6K | Completed | Generating Revenue |
Moligo Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Moligo Technologies Patents
Moligo Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202210224-D0 | Use of chimeric endonucleases | Inactive | 12-Jul-2022 | ||
| EP-4511502-A2 | Method for producing double stranded dna | Pending | 19-Apr-2022 | ||
| GB-202205696-D0 | Method for producing double stranded dna | Inactive | 19-Apr-2022 | ||
| US-20250250598-A1 | Method for producing double stranded dna | Pending | 19-Apr-2022 | ||
| WO-2023203082-A2 | Method for producing double stranded dna | Inactive | 19-Apr-2022 | C12P19/34 |
Moligo Technologies Signals
Moligo Technologies Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Vento (Venture Capital) | Venture Capital | Minority | ||
| Colibri Ventures | Venture Capital | Minority | ||
| Nordic Science Capital | Venture Capital | Minority | ||
| Phase2Phase Biopharma | Venture Capital | Minority | ||
| EIT Health | Accelerator/Incubator |
Moligo Technologies FAQs
-
When was Moligo Technologies founded?
Moligo Technologies was founded in 2019.
-
Where is Moligo Technologies headquartered?
Moligo Technologies is headquartered in Solna, Sweden.
-
What is the size of Moligo Technologies?
Moligo Technologies has 10 total employees.
-
What industry is Moligo Technologies in?
Moligo Technologies’s primary industry is Discovery Tools (Healthcare).
-
Is Moligo Technologies a private or public company?
Moligo Technologies is a Private company.
-
What is Moligo Technologies’s current revenue?
The current revenue for Moligo Technologies is .
-
How much funding has Moligo Technologies raised over time?
Moligo Technologies has raised $782K.
-
Who are Moligo Technologies’s investors?
Vento (Venture Capital), Colibri Ventures, Nordic Science Capital, Phase2Phase Biopharma, and EIT Health are 5 of 7 investors who have invested in Moligo Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process